PNPLA3-I148M shows reduced hydrolase activity and promotes hepatic triglyceride accumulation, all in line with the primary phenotype of NAFLD: fat accumulation in hepatocytes. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.